Video 2022-09-02
ISR Holding: Nigel Goodman Chief of Clinical operations presents at Redeye Initiate September 1st, 2022
Press release 2022-08-31
ISR Rapport för det första halvåret 2022
Press release 2022-08-29
ISR har nu stängt inklusionen till HIV studien ISR-003
Press release 2022-08-19
Nytt datum för Halvårsrapport 2022
Press release 2022-07-01
SARS-CoV-2 vaccine study approved by Bangladesh BMRC
Press release 2022-06-30
Uppdatering kring styrelsens sammansättning i ISR
Press release 2022-06-28
ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.
Video 2022-06-21
Redeye - Get to know Ola Winqvist
Press release 2022-06-20
Delegation from Bangladesh visits ISR for study preparation
© ISR Immune System Regulation Holding AB (publ). All rights reserved.
Retzius väg 11
SE-171 65 Solna, Sweden
Email: info@israb.se
Phone: +46 705 42 79 39